Noxopharm Limited Dividend 2022

Noxopharm Limited (NOX) is a clinical-stage Australian drug development company with offices in Sydney and New York. The Company has a primary focus on the development of Veyonda and is the major shareholder in Nyrada Inc, a spin-off company developing a pipeline of non-oncology drugs.

Noxopharm Limited operators in Health Care sector and under industry of Biotechnology. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

NOX Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found